EXPONENT INC·4

May 15, 8:56 PM ET

Corrigan Catherine 4

4 · EXPONENT INC · Filed May 15, 2026

Research Summary

AI-generated summary of this filing

Updated

Exponent (EXPO) CEO Catherine Corrigan Exercises Options, Sells Shares

What Happened

  • Catherine Corrigan, President & CEO and Director of Exponent (EXPO), exercised stock options on 2026-05-15 to acquire 5,606 shares (2,380 shares at $29.05 and 3,226 shares at $25.41), paying about $151,096 in exercise price.
  • On the same day she disposed of shares: two open-market sales totaling 4,194 shares at $54.06 per share for combined proceeds of $226,726. The filing also records derivative disposals of 5,606 shares (N/A price), consistent with shares surrendered in connection with the exercise. Footnote indicates the stock sale was to cover the option exercise price and taxes.

Key Details

  • Transaction date: 2026-05-15 (filed same day; timely).
  • Options exercised: 2,380 @ $29.05 (cost $69,139) and 3,226 @ $25.41 (cost $81,957) — total 5,606 shares, ~$151,096 paid.
  • Open-market sales: 1,827 @ $54.06 (proceeds $98,767) and 2,367 @ $54.06 (proceeds $127,959) — total 4,194 shares, ~$226,726 proceeds.
  • Derivative disposals: 3,226 and 2,380 shares shown as disposed (N/A price) — corresponds to exercised shares surrendered/withheld.
  • Footnotes: F1 — sales were to cover option exercise price and taxes; F2 — the option vests in four equal annual installments; F3 — not applicable.
  • Shares owned after transaction: not specified in the provided excerpt — see the full Form 4 for total beneficial ownership.

Context

  • This was an option exercise followed by share dispositions to cover the exercise cost and tax withholding (commonly called a cashless exercise/sell-to-cover). Exercises are purchases of stock via option conversion; subsequent sales to cover taxes are routine and do not necessarily indicate a change in insider sentiment.

Insider Transaction Report

Form 4
Period: 2026-05-15
Corrigan Catherine
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-15$29.05/sh+2,380$69,139107,598 total
  • Sale

    Common Stock

    [F1]
    2026-05-15$54.06/sh1,827$98,767105,771 total
  • Exercise/Conversion

    Common Stock

    2026-05-15$25.41/sh+3,226$81,957107,585 total
  • Sale

    Common Stock

    [F1]
    2026-05-15$54.06/sh2,367$127,959105,218 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    [F3][F2]
    2026-05-153,2263,225 total
    Exercise: $25.41Exp: 2026-07-29Common Stock (3,226 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    [F3][F2]
    2026-05-152,3807,138 total
    Exercise: $29.05Exp: 2027-02-16Common Stock (2,380 underlying)
Footnotes (3)
  • [F1]Stock sale was to cover the option exercise price and taxes.
  • [F2]The stock option becomes exercisable in four equal annual installments.
  • [F3]Not applicable.
Signature
By: Wendy Whitehouse For: Catherine Corrigan|2026-05-15

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT